95 related articles for article (PubMed ID: 25446930)
1. The ligand binding ability of dopamine D1 receptors synthesized using a wheat germ cell-free protein synthesis system with liposomes.
Arimitsu E; Ogasawara T; Takeda H; Sawasaki T; Ikeda Y; Hiasa Y; Maeyama K
Eur J Pharmacol; 2014 Dec; 745():117-22. PubMed ID: 25446930
[TBL] [Abstract][Full Text] [Related]
2. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
[TBL] [Abstract][Full Text] [Related]
3. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
4. Atypical SCH23390 binding sites are present on bovine adrenal medullary membranes.
Dahmer MK; Senogles SE
Neurochem Res; 2000 Mar; 25(3):321-6. PubMed ID: 10761974
[TBL] [Abstract][Full Text] [Related]
5. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
6. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
[TBL] [Abstract][Full Text] [Related]
7. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
[TBL] [Abstract][Full Text] [Related]
8. Effect of neuropeptide-EI on the binding of [3H]SCH 23390 to the dopamine D1 receptor in rat striatal membranes.
Sanchez MS; Salvatierra NA; Vettori G; Celis ME
Neurochem Res; 2001 May; 26(5):533-7. PubMed ID: 11513481
[TBL] [Abstract][Full Text] [Related]
9. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.
Wang HY; Undie AS; Friedman E
Mol Pharmacol; 1995 Dec; 48(6):988-94. PubMed ID: 8848015
[TBL] [Abstract][Full Text] [Related]
11. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
Ohnmacht U; Tränkle C; Mohr K; Gmeiner P
Pharmazie; 1999 Apr; 54(4):294-7. PubMed ID: 10234741
[TBL] [Abstract][Full Text] [Related]
12. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
Yokoyama C; Okamura H
J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
[TBL] [Abstract][Full Text] [Related]
13. Localization and characterization of dopamine D1 receptors in sheep hypothalamus and striatum.
Colthorpe KL; Curlewis JD
J Neuroendocrinol; 1996 Jul; 8(7):561-8. PubMed ID: 8843025
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with (-)-stepholidine alters density and turnover of D1 and D2 receptors in striatum.
Zou LL; Cai ST; Jin GZ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):485-9. PubMed ID: 9863137
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist.
Kassack MU; Höfgen B; Decker M; Eckstein N; Lehmann J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):543-50. PubMed ID: 12444495
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic ethanol treatment and ethanol withdrawal on [3H]SCH23390 binding to rat striatal membranes.
Gili-Martín E; Fernández-Briera A; Calvo P
Neuropharmacology; 1997 Jan; 36(1):101-6. PubMed ID: 9144646
[TBL] [Abstract][Full Text] [Related]
18. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
[TBL] [Abstract][Full Text] [Related]
19. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
20. [3H]A-69024: a non-benzazepine ligand for in vitro and in vivo studies of dopamine D1 receptors.
Kassiou M; Scheffel UA; Musachio JL; Stathis M; Dannals RF
Life Sci; 1995; 57(23):PL367-72. PubMed ID: 7475960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
